Epigenetic disruption of adipogenic gene enhancers in dedifferentiated liposarcomas and its therapeutic value.

Saved in:
Bibliographic Details
Title: Epigenetic disruption of adipogenic gene enhancers in dedifferentiated liposarcomas and its therapeutic value.
Authors: Hattori N; Department of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan.; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.; Laboratory of Integrative Metabolic Regulation, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan., Takamatsu H; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan., Iida N; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan., Asano N; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan., Yamashita S; Department of Life Engineering, Faculty of Engineering, Maebashi Institute of Technology, Maebashi, Japan., Oba GM; Laboratory of Computational Genomics, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, Japan., Kimura K; Laboratory of Integrative Metabolic Regulation, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan., Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Kobayashi E; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Nakayama R; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan., Matsumoto M; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan., Nakamura M; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Ushijima T; Department of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan.; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Source: Frontiers in oncology [Front Oncol] 2025 Apr 30; Vol. 15, pp. 1419877. Date of Electronic Publication: 2025 Apr 30 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1419877